Finance

Lists
SLXN:NASDAQ
Silexion Therapeutics Corp
US$ ०.२६
-०.३५%
(-०.०००९०) 1D
अक्टोबर ५, १४:४६:५७ GMT-४  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for SLXN...
Open
US$ ०.२६
High
US$ ०.२७
Low
US$ ०.२६
Mkt. cap
१४.९० लाख
Avg. vol.
२.०५ करोड
Volume
९.३५ लाख
52-wk high
US$ ४२.००
52-wk low
US$ ०.२४
EPS
-US$ ५६.४५
Beta
-०.२९
Shares outstanding
१.१० करोड
No. of employees
१४
Open
US$ ०.२६
High
US$ ०.२७
Low
US$ ०.२६
Mkt. cap
१४.९० लाख
Avg. vol.
२.०५ करोड
Volume
९.३५ लाख
52-wk high
US$ ४२.००
52-wk low
US$ ०.२४
EPS
-US$ ५६.४५
Beta
-०.२९
Shares outstanding
१.१० करोड
No. of employees
१४
News stories
From web sources and news partners
Simply Wall Street
Simply Wall Street
·
५ मिनेट पहिले
DiamondRock Hospitality Holders Are Up 41% And The Case Still Sits Uneasily
Yahoo Finance
Yahoo Finance
·
२१ मिनेट पहिले
Nasdaq Hits Fresh Highs While Dow Slips and Small Caps Struggle for Direction
Barron's
Barron's
·
४१ मिनेट पहिले
The S&P 500 Keeps Climbing as Many Stocks Struggle With Higher Rates
About Silexion Therapeutics Corp
CEO-
Employees१४
Founded२००८
Headquarters-
Sector-
Analyst ratings
Based on 1 analyst giving stock ratings to SLXN in the past 3 months
Hold
Buy
0
Hold
1
Sell
0
12-month forecast
Based on 1 Wall Street analyst offering 12-month price targets for SLXN in the last 3 months
Highest
Current US$ ०.२६
(-१००.००%)
Average
(-१००.००%)
Lowest
(-१००.००%)
Analyst
Recommendation
Action
Price target
Projected
Date
Naz Rahman
Maxim Group
Hold
Maintained
-
-
08/19/2026
Theodore O'Neill
Litchfield Hills
Buy
Initiated
US$ ६.००
+२,२१६.६%
12/15/2025
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
२०२५ सेप्टेम्बर
२०२५ डिसेम्बर
२०२६ मार्च
२०२६ जुन
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
२१.५७ लाख
३३.७५ लाख
१३.७० लाख
२२.१२ लाख
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
११.३५ लाख
१०.३१ लाख
१३.७९ लाख
१४.६८ लाख
Operating expense
३२.९२ लाख
४४.०६ लाख
२७.४९ लाख
३६.८० लाख
Total operating expenses
३२.९२ लाख
४४.०६ लाख
२७.४९ लाख
३६.८० लाख
Operating income
-३२.९२ लाख
-४४.०६ लाख
-२७.४९ लाख
-३६.८० लाख
Other non operating income
२३.०० हजार
-३५.०० हजार
११.०० हजार
१.५५ लाख
EBT including unusual items
-३२.६२ लाख
-४४.१२ लाख
-२७.३३ लाख
-३५.५१ लाख
EBT excluding unusual items
-३२.६२ लाख
-४४.१२ लाख
-२७.३३ लाख
-३५.५१ लाख
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-३२.६२ लाख
-४४.१२ लाख
-२७.३३ लाख
-३५.५१ लाख
Net profit margin
-
-
-
-
Earnings per share
-
-
-
-
Interest and investment income
३९.०० हजार
६९.०० हजार
३२.०० हजार
१४.०० हजार
Interest expense
-
-
-
-
Net interest expenses
३९.०० हजार
६९.०० हजार
३२.०० हजार
१४.०० हजार
Depreciation and amortization charges
-
-
-
-
EBITDA
-३२.८८ लाख
-४४.०३ लाख
-२७.४७ लाख
-३६.७७ लाख
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
Google एपहरू